Literature DB >> 28176623

Effect of Cinnamomum cassia on the Pharmacokinetics and Pharmacodynamics of Pioglitazone.

Sandhya Mamindla1, Venkata S R G P Koganti1, Nagaraju Ravouru1, Bharathi Koganti1.   

Abstract

BACKGROUND: Millions of people today use herbs either as food or in the form of medicine along with other medications. Many of the herbs can interact with these medications, causing either potentially dangerous side effects or improved or reduced benefits from the medication.
OBJECTIVE: The present study was performed to determine the influence of cinnamon, on the pharmacokinetics and pharmacodynamics of pioglitazone.
METHOD: Studies were conducted in normal and alloxan induced diabetic rats and rabbits with oral administration of selected doses of pioglitazone, cinnamon and their combination. Blood samples were collected at regular intervals of time and were analysed for glucose by GOD/POD method and for pioglitazone by HPLC method respectively. Body weights were also measured every week.
RESULTS: Significant differences were seen in pharmacokinetic parameters of pioglitazone like AUC, t1/2, Ke, Cl/F, Vd/F when given in combination with cinnamon in normal and diabetic rabbits. The combination of pioglitazone and cinnamon was found to reduce the glucose levels and body weights significantly than pioglitazone. The results indicating increased AUC of pioglitazone on pretreatment with cinnamon suggest an interaction indicating decreased metabolism of pioglitazone as a result of CYP 3A4 inhibition and thereby producing a potentiating effect.
CONCLUSION: Cinnamon enhanced the bioavailability of pioglitazone by inhibiting the CYP3A4 enzyme. Hence, cinnamon might be beneficial when used in combination with pioglitazone in diabetic patients and an adjustment of dose of pioglitazone may be necessary. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  CYP 3A4; Diabetes mellitus; GOD/POD; HPLC analysis; cinnamon bark powder; glucose levels; pioglitazone

Mesh:

Substances:

Year:  2017        PMID: 28176623     DOI: 10.2174/1574884712666170207152020

Source DB:  PubMed          Journal:  Curr Clin Pharmacol        ISSN: 1574-8847


  3 in total

1.  Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats: Impact on therapeutics.

Authors:  Ali M Alshabi; Saad A Alkahtani; Ibrahim A Shaikh; Mohammed S Habeeb
Journal:  Saudi Med J       Date:  2021-02       Impact factor: 1.484

Review 2.  Safety Profile of Nutraceuticals Rich in Coumarins: An Update.

Authors:  Simona Codruta Heghes; Oliviu Vostinaru; Cristina Mogosan; Doina Miere; Cristina Adela Iuga; Lorena Filip
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

3.  Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: systematic review and meta-analysis.

Authors:  Abdulaziz S Alzahrani; Malcolm J Price; Sheila M Greenfield; Vibhu Paudyal
Journal:  Eur J Clin Pharmacol       Date:  2021-03-08       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.